NOVERA RETATRUTIDE: THE NEW APPROACH FOR BODY CONTROL?

New clinical evidence suggests that Novera Retatrutide, a dual-action therapy from Novo Nordisk, could represent a meaningful breakthrough in weight management. Unlike many existing treatments, Retatrutide targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), potentially resu